504538914
`
`09/08/201 7
`
`PATENT ASSIGNMENT COVER SHEET
`
`Electronic Version v1.1
`Stylesheet Version v1.2
`
`EPAS ID: PAT4585621
`
`
`SUBMISSION TYPE:
`NEW ASSIGNMENT
`
`NATURE OF CONVEYANCE:
`ASSIGNMENT
`
`CONVEYING PARTY DATA
`
`Execution Date
`
`ALLERGAN, INC.
`
`09/08/2017
`
`
`
`
`
`
`
`
`
`RECEIVING PARTY DATA
`
`Name:
`SAINT REGIS MOHAWK TRIBE
`
`Street Address:
`412 STATE ROUTE 37
`
`City:
`AKWESASNE
`State/Country:
`NEW YORK
`Postal Code:
`13655
`
`
`PROPERTY NUMBERS Total: 6
`
`Property Type
`
`Patent Number:
`8629111
`
`Patent Number:
`8633162
`
`Patent Number:
`8642556
`
`Patent Number:
`8648048
`Patent Number:
`8685930
`Patent Number:
`9248191
`
`
`CORRESPONDENCE DATA
`
`(714)246-4249
`Fax Number:
`Correspondence will be sent to the e-mail address first; if that is unsuccessful, it will be sent
`using a fax number, if provided; if that is unsuccessful, it will be sent via US Mail.
`Phone:
`714—246—4500
`
`Email:
`Correspondent Name:
`Address Line 1:
`Address Line 4:
`
`patentsiip@allergan.com
`ALLERGAN, INC.
`2525 DUPONT DRIVE, T2—7H
`IRVINE, CALIFORNIA 92612-1599
`
`
`ATTORNEY DOCKET NUMBER:
`17618
`
`NAME OF SUBMITTER:
`LAURA L. WINE
`
`SIGNATURE:
`/Laura L. Wine/
`DATE SIGNED:
`09/08/2017
`
`Total Attachments: 6
`
`504538914
`
`PATENT
`REEL: 043532 FRAME: 0422
`
`SRMT 2103 - Pg. 1
`MYLAN PHARMACEUTICALS V. ALLERGAN
`|PR2016-01132
`
`SRMT 2103 - Pg. 1
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01132
`
`

`

`source=Short form-Patent Assignment -
`source=Short form-Patent Assignment -
`source=Short form-Patent Assignment -
`source=Short form-Patent Assignment -
`source=Short form-Patent Assignment -
`source=Short form-Patent Assignment -
`
`Signed#page6.tif
`
`Signed#page1.tif
`Signed#pageZ.tif
`Signed#pag93.tif
`Signed#page4.tit
`Signed#page5.tit
`
`PATENT
`REEL: 043532 FRAME: 0423
`
`SRMT 2103 - Pg. 2
`MYLAN PHARMACEUTICALS V. ALLERGAN
`|PR2016-01 132
`
`SRMT 2103 - Pg. 2
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01132
`
`

`

`EXECUYYGN Si’EKSIGN
`
`SHGRT FGRM EATENT ASSlGNMENT
`
`This mez Assignmsmt (this “Assignment? 5;: mafia as (23? Swimmer Sy 253i?
`{we}: dam, m "macaw; mm“), 553: and bemfiean Aifiasgm, km, a. Deiawam camomfim
`{"Assing’L ami Saint Ragis Mishemk ‘I'n‘bm a fedaraliy»mmgsized 3(3\’L*-R°§gfi Nafive
`Mummy: Tribe {*‘Assfigme’fi.
`
`WHEREAS” Amway BWfiS the patmis mi mien: appfiimtioas sat forth in
`Amachmsm A (the “Fammxfl;
`
`:8
`WHEREAS Assigmr desires: w agségn, {mafia cmwy and afieiiwx‘
`Assignm amfi Assignee Makes m acquine {mm 5555531501: 313 ofiés mam tifle 321d imam: m, (a
`and under the Fatwts; and
`
`WHERW‘S, pmaam my and upon {ha terms, @hligatfiflm amd soadiiions oi the
`Fawn: Assigmnmfi Agmmmm‘. data? as m? Sememfier K, 291'? (mg “ng hm) Agreement";
`by and hetwsaen Assignaf and 5555359,:ka Assigns: dwim; to cfilxfimz anti gaffe-c: its assignment,
`tmfisfi‘sr, wavaymme mid tia-Eiwxry t0 fixsigme: 0f fl} af its right, this: anti flaws: in, m anti
`Linda's ”aim Patemts anti Em ta ami under the: immzkiims ra§mcmm£ ihssteky, and Asgigmse is:
`dcsiraus 9f wafimimg and gerfsctiag than same,
`
`351:2: maeigt and
`Haw, T§-IEREFORE, for gwé and vaimafiic camidfimfim,
`sui‘ficiwcy (21‘ which are Esemhy ackmwwdged, the: pamiss hfimie,
`intanciiztg £9 52:: Iagafiy
`beam, hereby agree aa faliawy
`i. ism ,. As at? m Ef‘fastim flare, Assigmr hereby mnmyfi, immifirss assigm
`
`an
`:16 :ms :0 Awfigfica, and Axsigsase Rzemby accspm tbs Emir:
`:Kéfisigmr,
`3531 of
`Assignm‘°s figfié, title am mates: in m and amdfir the 5323mm, {Ogfihfifii‘ with any
`reiswess, z‘egxamismmn, divwong; goniinusxiiom‘ watinumism-iwpmfi, extermim‘ssv and
`mnwais of mh .kxsigmé E‘zitems airézady granted and which may Ev: granted iimmnn,
`'Fha: assiignmam mnmmpiaiesai Emmi“ is mam: 26: be an absaiui‘c awignmezm 313:5 mi by
`way 9f sac-writ}
`a»: ggggg‘. As may be mammary, Assignm simii cxamtm ackmwlezdgs and
`deliver such saber Maugham dacamam and ggmmwms 315:6 33m} do 333051 mixer
`{Mags as may be: mamnafiy gamma?» ympcr o: ndvigahifl ta} carry out its afligfitfiefis
`undsr this figmemem anzfi as may 3m reasmmbiiy gammy, pmgzar 9f advisaisie ta more:
`mmimety affflczima, ucfismmwm racerfi‘ parfact var
`(39361151 112::
`twasaciiexxs
`comfimpimfid hmehy‘
`L» IRW- The Assigmtvr hart-1&3}? autim'izss fig: fliz‘euzmr of Pawns; and 'l‘mdcmarkg
`ix} 555: united Stages Farm: and Tmeiemzrrit 85:39:»; {a} meow Amigakm as {556 asgignm
`and awe; of the; Asgégmxi I’afimfis grid to rieiiver to Axsigma, am m Agsignee‘se
`iatiismeymx agenm? samessoxs 01' 513555531555 53933 ui‘ficséai fimxfimesmzs 331:5 cmmmmicafléms as
`may be: warraniefl by (his Assigmami, inchxi‘mg best :10: limitmi 20 issumig any and 2312
`mfiefis :33th of shes: {555th Sam 9:; mvmmng ciaimex! in the micma
`
`4, Sgflgggg “333358 fiMmmszmnmgy. Awigime fewest-film 3323: it 59533; miami wiii
`nut waive im smemign immuniiy ca 2515 mves‘gign immunity af any campany,
`cmwmiiam eniea‘priasa, ammmy; divisimz.
`sums-55:59:23 122231132} or Omar 213mg};
`ixsstmmmiaiiw m 0:315: gm'mzment magmas: of Asfiignsc {each 0f fihe {bragging
`
`
`E
`
`
`
`it}
`”is?
`_
`
`\
`$16 ‘5 T
`”‘o‘lfi'sszggfixME: 0424
`REEL‘?
`
`SRMT 2103 - Pg. 3
`MYLAN PHARMACEUTICALS V. ALLERGAN
`|PR2016—01132
`
`SRMT 2103 - Pg. 3
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01132
`
`

`

`Us
`
`Emludisag Assignm, a “Tribal Party“), in each case, in mimism in any inter paftfls:
`mvicw 532‘ any 061:): pmcceding in the United Siam Patent 8; Ymdemm'k Officz: 23:- any
`adminismarfiva pmcm‘iiug that may be filed far the gamma af imafiéatmg {if mnficx‘ing
`mafia-mafia any Agsigmd Faifimg. For gamma :1?“ this. Assigxmmnt Agreement. :19
`
`yams km 9f1his Asgignmcmt Aggiefimsm :‘x‘mmié be: imammtafi in commute a waiver 3f
`Assignes’s 9r may 0321a: Triml Pariy‘é Sawmigm immusiiiy 3.3 m any image: panes. mview
`or simimr gummmfizggs.
`
`Qggergifig (“>333 Awigmr amfi Assigme each ackmwisdge and agree that me
`Ngmsexzmtiskm, warremties. cmmmus, abligafiimm and “the: terms mismisti in {he
`Lang Perm Agz‘efimfiem 532w mt be summedslsd Emmby. but 331.523.! mmaifi it} fail fame:
`magi fifiest it: the fuii Mien: pmvés‘éysd therein. T0 the extent em: any pmviaim 13‘? this
`Assignmem is incamiisicm at mnflicfi; with {th Lang Form Agreemem, the gkmvésimm
`afi‘ me Lcng Form Agmamem shafi controi. The pas-figs may smegma: tfiis Agsigmnfim
`in muizs‘pis cmmmmm, my me <33“ which new no: mama} fihe sigmum afmcm than
`em: party, but a2; mafia wantergsmm mm togmkezr simfi wastimie am: and the same,
`insatmmwi. Any emulate-$33 rm}; 5):: sxecami by facsimiia 0r FD? signatm and such
`faasiimile or PB}? aigtmmm shag be dammed 1m original. The {was and cqmdiiims of
`this Assignment shaii $36 "(simimg “my: the: pafiigs karma and their msmcfiw mmstesmm
`anti amgm, This Assigmmcm mm be“: governed h); and cm‘xstmed in maximum with
`the 3am af the Strata of New Yam, Milan“: givixxg effect to £3.16 mummies cfmnfiium
`{2f Efiw thmeuf.
`
`{figmmms $33,219:» 932 The fifiimving Page}
`
`in}
`
`t
`
`Mai), 7.32
`z
`-« g
`“NT A
`
`afiwsi‘g‘RAME: 0425
`
`.
`
`REE
`
`SRMT 2103 - Pg. 4
`MYLAN PHARMACEUTICALS V. ALLERGAN
`|PR2016—01132
`
`SRMT 2103 - Pg. 4
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01132
`
`

`

`EN WET‘NE SS THEEREGF, Assigns: anti Aasigncr: haw: musm their «septum-4: duly
`authorized (3113::me to enema mix Asxigunsm as {:3f the Efiemiw Dana,
`
`Sam“ Regis Mshawk "Erika“:
`
`Allergyn, fins;
`
`
`
`Mama: Brig: Thompgqm
`
`Mama: A. Rabat: E? Bailey
`
`Title: Erika} Chief
`
`"rifle:
`
`i’msidmt
`
`
`
`Nar'éae: Beverly {Twig
`E‘ifle: Tfibasi Chief
`
`
`
`Name: Miahaei (Tamers
`
`This: Tribal Chief
`
`
`
`SRMT 2103 - Pg. 5
`MYLAN PHARMACEUTICALS V. ALLERGAN
`|PR2016-01 132
`
`SRMT 2103 - Pg. 5
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01132
`
`

`

`Atiacéfimgm A”2‘22: 9212:1222.
`
`S'X’A-‘TIJSSCGMMEKHETS
`13222223222222:
`3
`.. “2......222.”
`“2&4“.».~.~.._.~..MMN2.““
`2~\§2y~994
`22422-2222
`
`:
`
`ififfiflfifi’ég
`§22NM31232 E
`
`«9‘2“222
`1223:2024.
`2322573153 M¥£§Au~2023
`33.19%“? {7‘}
`Efi 2223223
`
`21-Feb-2314
`
`{21222-2222
`
`WT 2522212225 E
`
`fl’fiAquQ‘E
`w
`
`:12?«Augfl913
`1312221318
`
`1§~&)St—~?QQE
`
`
`
`2222231222
`
`:2:222,4:2
`
`22221122012
`
`K225222222 i
`
`12212222122222
`22222202122
`
`2322218§§__ 0?Augflfilfi
`_232822222 W 2.2233232?
`
`
`MISS}, 1 3?
`.2
`Lapsesi 2222222221
`NEWESS?
`Abmxdomsd
`
`22Nov2222
`“125221262
`
`.
`
`2222220222
`Ahaxsflmxmfi
`
`232222222
`312353432”.
`
`2354???£383
`
`3 1/182531:3
`lilfl’EAQiS
`
`5
`
`3
`E
`
`112122202 ;
`1321222 .
`g
`222220222
`www.222mm WWW
`ilffiififiii
`§
`
`
`
`
`
`REE€E&'D4352 FRAME. 0427
`
`SRMT 2103 - Pg. 6
`MYLAN PHARMACEUTICALS V. ALLERGAN
`|PR2016-01 132
`
`SRMT 2103 - Pg. 6
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01132
`
`

`

`
`
`
`3 12%le€253
`
`
`2522:2025 ;
`14252255; """
`=
`
`
`
`i 2mr.25;5
`______________{2mffiing
`5
`“T3225555558
`
`.2552?
`1222212225
`232::52255
`"""
`‘51}
`:2
`28425520222
`
`
`
`
`=
`
`"""""""""""""""
`
`25252553505
`
`23222126021225};
`
`
`525255551
`
`
`Abandmesci
`
`
`
`
`
`
`{42:25:52.2 Pravisimmi
`“mm“
`
`“"‘V
`
`
`Abandomé
`
` _......_ “22.2-5.4
`
`lapsed vaisim‘tai
`
`
`1.29m: vaisimxai
`
`
`2523552522 WW‘‘‘‘‘ M“
`
`
`
`
`
`REKW4353§§FRAME 0428
`
`SRMT 2103 - Pg. 7
`MYLAN PHARMACEUTICALS V. ALLERGAN
`|PR2016-01 132
`
`SRMT 2103 - Pg. 7
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01132
`
`

`

`««wm«
`1‘3“"me Na.
`
`Sums I Cemmg’gs
`
`
`
`mum me
` : SERIAL 31:1,.
`
`
`
`
`
`5m 174,334
`R “Marl-160?
`u {$331126 vais§¢§z§i_
`.
`
`
`
`
`51:341351
`iayé‘fllié E
`
`
`
`Maywzml
`1312:3364
`_.
`.
`
`
`
`2.7-ecrazm4
`141524355
`
`
`
`
`
`Abanéomd
`25mm???”
`16~Ap¥2014
`ifiwAquMB Abamgnmd
`
`
`
`33‘9”??::?~§15
`
`
`
`
` Ayvzfii 4
`Aimndoncd
`M EfibJEQEé V
`
`
`
`
`A? mwkrzwut .(‘K it! Sims"; Farm Pamni Amignmwrs Agreement
`
`F1?
`
` ’2'”9”an:”Vina”,
`
`”"A2
`
`
`
`
`RECORDED: 09/08/2017
`
`PA fit}
`REEL:0435
`FRAME:
`
`6429
`
`SRMT 2103 - Pg. 8
`MYLAN PHARMACEUTICALS V. ALLERGAN
`|PR2016-01 132
`
`SRMT 2103 - Pg. 8
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01132
`
`